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1. Introduction
  Uterine leiomyomas were characterized by an increase in smooth 
muscle cells (SMCs) proliferation and excessive deposition of 
extracellular matrix proteins, primarily collagens type I and III[1,2]. 
Formation of leiomyomas was viewed as a multistep process, with 
involvement of ovarian steroid hormones, cytokines and growth 
factors. Steroid hormones induced mitogenic effects directly 
through their receptors or by regulating expression of growth factors 
such as epidermal growth factor (EGF) and platelet derived growth 
factor (PDGF) and their respective receptors[3]. Mitogen-activated 
protein kinase (MAPK) signal pathway was the main transduction 
path which can regulate cell growth, proliferation and differentiation 
and so on[4-6]. Many tumors, through autocrine or paracrine modes, 
could produce EGF which could combine with EGFR to form a 
dimer, activating their inherent tyrosine kinase and consequently 
activating the signal pathways in cells (such as MAPK pathway)[7,8]. 
  In the study, human myometrial smooth muscle cells (HM-SMCs) 
and smooth muscle cells of human uterine leiomyomas (HL-SMCs) 
were processed by EGF, and then we investigated the trends of the 
phosphorylation levels of p44/42 MAPK in order to explore the role 
of EGF in the pathogenesis of uterine leiomyomas.
Objective: To  investigate the role of epidermal growth factor (EGF) in the pathogenesis of 
uterine leiomyomas. Methods: Human myometrial smooth muscle cells (HM-SMCs) and 
smooth muscle cells of human uterine leiomyomas (HL-SMCs) were separated from patients’ 
specimens and cultured. After processed by EGF or PD98059 (inhibitor of MKK/MEK) +EGF, 
the proliferation rate of both SMCs was detected by BrdU method and the phosphorylation 
level of p44/42 mitogen-activated protein kinase (MAPK) was determined by Western-blot. 
After different processing time by EGF, the phosphorylation levels of p44/42 MAPK and 
AKT and p27 expression level in both SMCs were detected by Western-blot. Results: EGF 
could significantly promote HL-SMCs proliferation and PD98059 could inhibit this effect 
(P<0.05); besides, PD98059 could inhibit the increase of the phosphorylation level of p44/42 
MAPK in both SMCs induced by EGF. When the processing time by EGF was over 15min, 
the phosphorylation levels of p44/42 MAPK and AKT in both SMCs decreased sharply and 
were close to zero; p27 expression in HM-SMCs raised significantly while the upregulation in 
HL-SMCs was little. Conclusions: EGF could not cause activation of EGFR because of the 
dephosphorylation of p44/42 MAPK and AKT in HL-SMCs, which caused p27 expression 
insufficiently and cell cycle dysregulation.
IF: 0.926
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 2. Materials and methods
2.1. Cultivation of SMCs 
  10 human uterine leiomyomas specimens and 10 normal 
myometrium specimens from cervical intraepithelial neoplasia 
patients undergone the total hysterectomy were collected after 
informed consent. Then the uterine leiomyomas and normal 
myometrium were separated and cut into pieces. Then the pieces 
were placed into 25 cm3 culture flask with 0.1% collagenase I in 5% 
CO2 incubator at 37 曟 for 5-6 h. After the pieces were digested into 
single cells, they were centrifuged at 1 000 rpm for 8min and beat 
repeatedly with dulbecco’s modified eagle medium (DMEM) for 
adjusting concentration at 1伊105 cells/mL. After that, the cells were 
incubated in 5% CO2 incubator at 37 曟[9]. 
2.2. Bromodeoxyuridine (BrdU) method 
  HM-SMCs and HL-SMCs in logarithmic phase were plated in 96-
well plate at 5伊104 cells/mL and grew to confluence. Then the cells 
were processed, the processing design was as followed: a: control 
cells in DMEM; b: cells in DMEM with EGF (100 ng/mL, for 24 h); 
c: cells pretreated with 20 毺M PD98059 (inhibitor of MKK/MEK, 
for 1h) in DMEM + EGF (100 ng/mL, for 24 h). 
  When the processing time by EGF was left 1 hour, the medium 
was switched to culture medium containing 10 毺M BrdU and cells 
were incubated for 1 hour. BruU incorporation rate was measured 
by using a microplate reader. Three independent experiments were 
performed, and each assay was carried out in triplicate.  
             
2.3. Western-blot 
  After being starved for 24h, the cells were processed by 100 ng/
mL EGF for 15 min; besides, PD98059 was added before EGF in 
another group and the experimental design in detail was according 
to 2.2. After the cells were lysed and went through the incubation of 
primary antibody and secondary antibody, the grey value of target 
protein was measured by Quantity One software.
  In order to observe the trends of the phosphorylation levels of 
p44/42 MAPK and AKT and expression level of p27, both SMCs 
were processed by 100 ng/mL EGF for 15min, 30min, 60min, 
120min and 240min, respectively. And then, the cells were collected 
at different time points. The target proteins expression level were 
detected and measured.
2.4. Statistical analysis 
  SPSS18.0 was used for statistical analysis, all the data were showed 
by mean依SD. Statistical analysis was performed using One-Way 
ANOVA with Dunnett’s multiple comparisons test. P<0.05 was 
considered to be statistical significance.
 
3. Results
3.1. Effect of EGF on phosphorylation of p44/42 MAPK 
  After the processing by EGF, the phosphorylation level of p44/42 
MAPK in both SMCs increased significantly (P<0.05), and it was 
remarkably higher in HM-SMCs than in HL-SMCs (P<0.05) (Figure 
1, Table 1).
HM-SMCs                HL-SMCs
EGF, 15 min
p-p44/42 MAPK
p44/42 MAPK
毩-tubulin
 
Figure 1. Influence of EGF on phosphorylation level of p44/42 MAPK in 
HM-SMCs and HL-SMCs.
3.2. PD98059’s effect on cell proliferation and p44/42 MAPK 
phosphorylation induced by EGF
  Figure 2a showed that EGF could significantly promote the 
proliferation only in HL-SMCs (P<0.05). However, PD98059 could 
inhibit this promotion effect (P<0.05). Besides, PD98059 could 
inhibit the increase of the phosphorylation level of p44/42 MAPK in 
both cells induced by EGF (Figure 2b).
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Figure 2. Influence of PD98059 on phosphorylation of p44/42 MAPK and 
proliferation rate in both SMCs.
Note: *: compared with control group, P<0.05; #: compared with EGF group, 
P<0.05.
Table 1 
Relative expression level of p44/42MAPK and p-p44/42MAPK protein before and after the treatment of EGF.
HM-SMCs HL-SMCs
EGF(-) EGF(+) EGF(-) EGF(+)
p44/42MAPK 1.38依0.19 1.43依0.21 1.41依0.25 1.47依0.24
p-p44/42MAPK 0.28依0.06 0 .90依0.14# 0.22依0.05    0.42依0.09*#
Note: *After the same treatment, in HM-SMCs vs in HL-SMCs, P<0.05; #in the same SMCs, before treatment vs. after treatment, P<0.05.
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3.3. EGF affected phosphorylation of p44/42 MAPK and AKT 
and p27 expression
  When the processing time of EGF was over 15min, the 
phosphorylation level of p44/42 MAPK and AKT in both SMCs 
decreased. The decreasing amplitude in HL-SMCs was more obvious 
than that in HM-SMCs, the phosphorylation rate in HL-SMCs was 
close to 0 (Figure 3). P27 expression level in HM-SMCs induced 
by EGF increased significantly while the increase in HL-SMCs was 
little.
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Figure 3. Phosphorylation level of p44/42 MAPK and AKT and expression 
level of p27 in HM-SMCs and HL-SMCs after being processed by EGF.
 
4. Discussion
  EGF was a kind of strong mitogen, which could stimulate the 
division and proliferation of multi-type cells and participated in the 
regulation of multiple physiological and pathological functions[10,11]. 
In the study, EGF obviously raised the phosphorylation level of 
p44/42 MAPK in both SMCs and cell proliferation in HL-SMCs, 
while PD98059 could inhibit this up-regulation. These results 
implied that p44/42 MAPK, as the downstream signal factor of 
EGFR-MEK signal pathway, played an important role in the 
regulation of DNA synthesis in HL-SMCs[12,13]. With the processing 
time passed, the inhibitory effect on the activation of p44/42 MAPK 
in HL-SMCs was becoming more and more serious, but this 
inhibitory effect in HM-SMCs was quite weak. 
  A role of EGF in leiomyoma growth was supported by the fact that 
the selective EGF-R blocker AG1478 was able to block leiomyoma 
cell proliferation[14]. Mesquita et al[15] firstly proved in their study 
that reactive oxygen species (ROS) produced by NAPDH oxidase 
system of LSMCs participated in the regulation of transduction 
pathway of growth factor signals, and they thought LSMCs produce 
ROS in response to EGF. Our study showed PD98059 could inhibit 
DNA synthesis in HL-SMCs as well as the increase of p44/42 
MAPK phosphorylation level induced by EGF in both SMCs[16]. In 
the study of molecular mechanism by which genistein induced the 
excessive proliferation of uterine leiomyoma cells, Di et al[9] found 
that after the processing of genistein, the trans-activation of estrogen 
receptor, the expression of mRNA of estrogen responsive gene, 
progesterone receptor, IGF-1 all increased while the use of PD98059 
can inhibit the up regulation and the excessive proliferation of 
uterine leiomyoma cells caused by genistein. In the study, after the 
processing of EGF, the expression level of p27 in HM-SMCs was 
drastic and steady while it rose a little in HL-SMCs. Therefore, we 
speculated that in HM-SMCs, through promoting the activation 
of p44/42 MAPK sharply and steadily, the expression level of p27 
raised sufficiently and thus ensured the cell cycle to function well[17]. 
But in HL-SMCs, EGF led the phosphorylation level of p44/42 
MAPK or AKT to be close to 0, which impossibly led to the above-
mentioned occurences happened. Eventually, the cell cycle could not 
function well in HL-SMCs[18-20].
  Currently, there are many therapies inhibit the development of 
tumors through preventing the activation of EGFR[21-24]. Though we 
certified the role of EGF in the pathogenesis of uterine leiomyomas 
in vitro, there is a needing for testifying its role in vivo.
  In summary, EGF could not cause the activation of EGFR 
because of the dephosphorylation of p44/42 MAPK or AKT in HL-
SMCs, which caused p27 expression insufficiently and cell cycle 
dysregulation.
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